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Abstract
The University of British Columbia Nepal Expedition took place over several months in the
fall of 2016 and was comprised of an international team of 37 researchers. This paper
describes the objectives, study characteristics, organization and management of this expe-
dition, and presents novel blood gas data during acclimatization in both lowlanders and
Sherpa. An overview and framework for the forthcoming publications is provided. The expe-
dition conducted 17 major studies with two principal goals—to identify physiological differ-
ences in: 1) acclimatization; and 2) responses to sustained high-altitude exposure between
lowland natives and people of Tibetan descent. We performed observational cohort studies
of human responses to progressive hypobaric hypoxia (during ascent), and to sustained
exposure to 5050 m over 3 weeks comparing lowlander adults (n = 30) with Sherpa adults
(n = 24). Sherpa were tested both with (n = 12) and without (n = 12) descent to Kathmandu.
Data collected from lowlander children (n = 30) in Canada were compared with those col-
lected from Sherpa children (n = 57; 3400–3900m). Studies were conducted in Canada
(344m) and the following locations in Nepal: Kathmandu (1400m), Namche Bazaar
(3440m), Kunde Hospital (3480m), Pheriche (4371m) and the Ev-K2-CNR Research Pyra-
mid Laboratory (5050m). The core studies focused on the mechanisms of cerebral blood
flow regulation, the role of iron in cardiopulmonary regulation, pulmonary pressures, intra-
ocular pressures, cardiac function, neuromuscular fatigue and function, blood volume
regulation, autonomic control, and micro and macro vascular function. A total of 335 study
sessions were conducted over three weeks at 5050m. In addition to an overview of this
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expedition and arterial blood gas data from Sherpa, suggestions for scientists aiming to per-
form field-based altitude research are also presented. Together, these findings will contrib-
ute to our understanding of human acclimatization and adaptation to the stress of residence
at high-altitude.
Introduction
The study of human physiology during acute and chronic exposure to high-altitude informs
our understanding of the physical response to reduced oxygen availability. Hypoxemia, such
as that experienced at high-altitude, is also a stress common amongst critically and chronically
ill patients. There is, however, a markedly heterogeneous response between individuals to the
same stimuli [1,2]. At sea-level, simulated hypoxic stress can be achieved through exposure to
a reduced inspired oxygen fraction in an enclosed environment (e.g. hypoxic chambers or
tents) and is a useful laboratory based approach for the study of acute hypoxic exposure. Such
an approach is problematic for the study of acclimatization processes and long-term hypoxic
exposure. This is predominately because of the complexities of conducting a lengthy study in
the confines of a small chamber. Field expeditions have therefore long been the modus ope-
randi of physiologists interested in the physiological responses to high-altitude [3]. These expe-
ditions are notable, not just for their substantial contributions to the natural sciences, but also
for the logistical hurdles and physical hardship of living and conducting research at altitude.
Understanding biological adaptation to the chronic environmental stress of living at high-
altitude necessitates a long period of study and, ideally, comparison between sea-level natives
and humans native to high-altitude. In high-altitude populations, modernization, migration,
and the consequent genetic admixture is rapidly occurring; therefore, study of the physiologi-
cal ramifications of human evolution to high-altitude is of immediate scientific importance
[4]. Approximately 40,000 years ago, a human migration into the Tibetan plateau occurred
with high incidence of two gene variants acquired through admixture with Denisovan popula-
tions [5]. This distinct genetic haplotype facilitates higher birth weight, lower infant mortality,
reduced hematocrit, and the legendary exercise performance at high-altitude for which the
Sherpa people of the Khumbu region of Nepal are famous. However, delineation of the specific
mechanisms involved in their superior physiological function at altitude remains undefined,
and the window of opportunity to study these mechanisms is quickly closing.
Of the multitude of physiological adaptations that occur upon ascent to altitude, increased
alveolar ventilation is the most important. This response mitigates the drop in the partial pres-
sure of arterial oxygen (PaO2) by increasing alveolar PO2 at any given inspired PO2. Despite
the importance of this adaptation, the phenotypic differences related to alveolar ventilation at
altitude that may (or may not) be present between Sherpa and lowlanders have yet to be clearly
demonstrated, with variable findings throughout the literature (reviewed in: [6]).
The purpose of this manuscript is two-fold: First, it aims to provide a summary of the 2016
University of British Columbia (UBC) expedition to the Khumbu region of the Nepal Hima-
laya. The principal scientific themes of the expedition along with the more notable aspects
of its execution are discussed herein. Given the logistical nature of high-altitude expeditions,
data overlap for independent variables is often unavoidable due to the costs associated with
repeated measurement/sampling (e.g., extra consumables, shipping, disposal) [7]. Thus, for
the purposes of transparency we present the arterial blood gas data upon ascent to altitude for
all subjects measured, including the Sherpa; the results and specific primary outcome variables
UBC-Nepal Expedition to Nepal Himalaya
PLOS ONE | https://doi.org/10.1371/journal.pone.0204660 October 31, 2018 2 / 17
Funding: The work conducted in this project were
supported by P. N. Ainslie (Canada Research Chair
in Cerebrovascular Physiology and National
Sciences and Engineering Research Council
(NSERC) Discovery Grant). C.K. Willie was
supported by an NSERC Post-Doctoral
Scholarship, R.L. Hoiland and M.M. Tymko were
supported by an NSERC Alexander Graham Bell
Canada Graduate Scholarship.
Competing interests: The authors have declared
that no competing interests exist.
of individual and experimentally unique studies will be published as discrete papers. Second,
we aim to highlight phenotypic differences in arterial blood gases between Sherpa and low-
landers during ascent to altitude to provide a novel insight into the effect of race on the accli-
matization process to high-altitude.
Methods
Overview
The UBC Nepal Expedition was undertaken in September to November 2016, with baseline
studies conducted over the two months prior. The research group was comprised of 37
researchers with key leadership from UBC, Cardiff Metropolitan University, University of
Alberta, Duke University Medical Centre, Loma Linda University, University of Cambridge,
and Bangor University. Studies were designed to either measure a physiological change from
(i) a baseline elevation (344m, UBC, Kelowna, BC, Canada in lowlanders; 1400m, Kathmandu,
in Sherpa), (ii) a difference between Sherpa and lowlanders during ascent or after acclimatiza-
tion at 5050m, or (iii) a difference before and after a pharmacological intervention(s) at alti-
tude (5050m, Ev-K2-CNR Research Pyramid Laboratory, Khumbu Valley, Nepal). In total,
335 study sessions comprising 17 distinct studies were completed over three weeks, an over-
view of which is given in the text and Table 1.
Subjects
Fig 1 provides a schematic breakdown of the study cohort. The research participants for these
studies were comprised of five groups totaling 141 participants (Fig 1): 1) 30 lowlander adults;
2) 12 Sherpa adults who de-acclimatized at 1400m for 9 ± 3 days (Age: 34±11, BMI: 24±4)—
three of the Sherpa in this group summited Mount Everest (8848 m) in the previous year; 3) 57
Sherpa children; 4) 30 age and BMI-matched lowlander children tested in Canada at 344m;
and, 5) 12 Sherpa adults (Age: 23±7, BMI: 21±2) who had not recently been below 3500m -
these Sherpa reached a maximum altitude of 4800 m to 7800 m (median: 5545 m) in the last
year.
All lowlanders were of European ancestry born at and living below 1000m, except one
lowland Nepali born at 1400m but living at sea-level and without any known ancestry from
native high-altitude populations. Studies had different sample sizes pooled from the same
cohort. Lowland expedition members were included in 1–6 experiments, and thus visited the
UBC laboratory on 2–6 occasions for the baseline arm of each study. Sherpa did not visit
UBC; Sherpa baseline measures were collected either in Kathmandu (n = 12) for those indi-
viduals who were ascending to 5050m with the research team, or at 5050m preceding any
interventional study (n = 12; see Table 1 and Fig 1 for individual study breakdown). Those
12 Sherpa that were part of the ascent studies arrived in Kathmandu 9 ± 3 days prior to re-
ascent to altitude. Direct descendants of at least two known generations of Sherpa were
recruited from local villages of the Solokhumbu valley by word of mouth. A detailed altitude
history was collected from all Sherpa participants including altitudes in utero, at birth, during
childhood, in adulthood, and for the 12 months preceding the studies. Prior to any study at
low or high-altitude, participants abstained from exercise and caffeine for a minimum of 12
hours, and were fasted for at least two-hours. Due to the number of studies needing to be
completed in a small period of time, 2–5 laboratories often ran simultaneously. Each study
that involved a pharmacological intervention was separated from subsequent studies by at
least five times the drug half-life to minimize any confounding influence of drugs across
studies.
UBC-Nepal Expedition to Nepal Himalaya
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Table 1. Core studies conducted on the UBC expedition, including objectives, key measures and sample sizes.
Study Study Title Aim Sample size Intervention / techniques
Ascent studies
1 Comparative effects on the pulmonary
vasculature of ascent to high-altitude in
lowlanders and high-altitude natives.
To characterize pulmonary arterial and right
ventricular function during ascent to high-
altitude, and how these parameters are
ameliorated by supplemental oxygen.
19
lowlander
12 Sherpa
Echocardiography; O2 supplement; blood pressure.
2 Cerebral vascular regulation in
lowlanders and Sherpa upon ascent to
5050m.
To assess if evolutionary adaptation to hypoxia is
reflected in phenotypical differences in CBF
regulation between lowlander and Sherpa during
graded hypoxia.
21
lowlanders
23 Sherpa
Duplex ultrasound; blood pressure; blood gases.
3 A non-invasive approach to the
pathophysiology of acute mountain
sickness.
To assess the predictive relationship between
optic nerve sheath diameter and acute mountain
sickness using known physiological ramifications
of ascent to high-altitude.
30
lowlanders
ONSD; head-down tilt; blood pressure.
4 Peripheral vascular function in
lowlanders and Sherpa upon ascent to
5050m.
To assess if evolutionary adaptation to hypoxia is
reflected in phenotypical differences in
peripheral vascular regulation between lowlander
and Sherpa during graded hypoxia.
22
lowlander
12 Sherpa
Duplex ultrasound; blood pressure; blood gases.
5 Iron metabolism during ascent to high-
altitude: lowlanders versus high-
altitude natives.
To examine changes in iron regulation during
ascent to 5050m in lowland and highland
natives.
21
lowlanders
12 Sherpa
Echocardiography; O2 supplement; blood pressure;
arterial and venous blood samples.
6 Cerebral autoregulation during
transient hypotension.
To examine the cerebral blood flow response
during a brief reduction in blood pressure in
both lowlanders and high-altitude natives upon
ascent to 5050m.
10
lowlanders
10 Sherpa
Duplex ultrasound; O2 supplement; blood
pressure.
Laboratory studies
7 Central effects of exercise in Sherpa
children at high-altitude.
To determine resting regional and global
cerebral blood flow in Sherpa children living at
high-altitude and lowlander children residing at
sea-level and ii) to characterize the effects of
progressive exercise to exhaustion on ventilation
and cerebral blood flow velocity in Sherpa
children at high-altitude and lowlander children
residing at sea-level.
30 lowland
children
57 Sherpa
Children
Duplex ultrasound; blood pressure; respiratory gas
exchange; cycle ergometer.
8 Neuromuscular fatigue in lowlanders
and Sherpa upon ascent to 5050m.
To assess the impact of hypoxia and
acclimatization on fatigue-induced changes
within the central nervous system and the muscle
in lowlanders and Sherpa.
12
lowlanders
10 Sherpa
Surface EMG; isometric myograph; muscle-belly
stimulation; TMS; CMS; BPS; duplex ultrasound;
NIRS.
9 Motor control and adaptation to high-
altitude.
To assess motor unit behaviour and motor
performance in lowlanders and Sherpa.
11
lowlanders
11 Sherpa
Intramuscular and surface EMG, isometric
myograph.
10 The role of iron and the hypoxia-
inducible factor system in the
pulmonary vascular response to
altitude.
To examine the role of iron in raised pulmonary
arterial pressures in hypoxia and to compare
between Sherpa and lowlanders.
20
lowlander
19 Sherpa
Echocardiography; O2 supplement; hypoxic gas;
blood pressure; arterial and venous blood samples;
cycle ergometer; iv–Iron (200mg) or DFO (4g).
11 Sympathetic function at high-altitude:
lowlanders versus high-altitude natives.
To examine the effect of acute and chronic
hypoxia on sympathetic activity and neural
transduction and to contrast the impact of
hypoxia on lowlanders and high-altitude natives.
14
lowlander
8 Sherpa
Vascular ultrasound; O2 supplement; hypoxic gas
mix; blood pressure; arterial and venous blood
samples; microneurography.
Oxford technique [SNP (20ug / L blood volume) vs
PE (30ug / L blood volume)].
12 Oxidative stress and cerebral blood
flow at high-altitude.
To examine the role of oxidative stress on
cerebrovascular function during acute and
chronic hypoxia in humans.
16
lowlanders
Duplex ultrasound; TCD; blood pressure;
respiration; oral antioxidants (500 mg vitamin C,
400 IU vitamin E and 300mg -αlipoic acid).
13 The mechanisms governing oxygen
content mediated regulation of cerebral
blood flow during acute and chronic
hypoxia.
To determine the role of arterial oxygen content
versus arterial oxygen tension in regulating
cerebral blood flow in acute and chronic
hypoxia.
17
lowlanders
Vascular ultrasound; O2 supplement; hypoxic gas;
blood pressure; arterial and venous blood samples;
hemodilution.
(Continued)
UBC-Nepal Expedition to Nepal Himalaya
PLOS ONE | https://doi.org/10.1371/journal.pone.0204660 October 31, 2018 4 / 17
Medical screening & safety
Thirty healthy lowlander adults were recruited from the members of the expedition (Table 2).
Participants between the ages of 18–55 years without medical history of cardiopulmonary,
cerebrovascular, or metabolic disease were considered for inclusion. Venous blood samples
were collected and analyzed for complete blood count, serum iron, ferritin, and transferrin sat-
uration. A Nepali physician (P. Subedi or S. Niroula) conducted complete medical histories for
all Sherpa volunteers.
Table 1. (Continued)
Study Study Title Aim Sample size Intervention / techniques
14 Shear stress and the endothelium
during acute and chronic hypoxia in
humans.
To determine whether endothelial function is
preserved or worsened by periods of imposed
retrograde shear stress during acute and chronic
hypoxia.
15
lowlanders
Vascular ultrasound; venous blood sample.
15 The role of absolute blood volume and
cardiac function in limiting maximal
exercise performance in Sherpa.
To assess absolute blood volume in high-altitude
Sherpa, and investigate the relationships between
blood volume, hemoglobin mass and cardiac
structure and function with maximal exercise
capacity.
12 Sherpa Echocardiography; blood pressure; arterial and
venous blood samples; cycle ergometer. Blood
volume was assessed at sea-level using the carbon
monoxide rebreathing method [8], as previously
used at high-altitude [9] (1ml kg-1 of CO).
16 The role of ß-adrenergic-dependent
and–independent factors in the
regulation of left ventricular twist in
hypoxia.
To investigate the independent and combined
influences of altered O2 saturation and
adrenergic stimulation on left ventricular twist
mechanics in hypoxic environments.
20
lowlanders
Echocardiography; blood pressure; infusion of
Esmolol (cardiac specific β1-adrenergic receptor
antagonist) as a 500 μg/kg bolus over 1 minute
followed by 150 μg/kg/min continuous
maintenance infusion.
17 The role of sympathetic nervous
activity on brachial artery endothelial
function at sea-level and high-altitude.
To determine the effects of acute and mild
alterations in sympathetic nervous activity via
lower-body differential pressure on vascular
function assessed via brachial artery flow-
mediated dilation.
15
lowlanders
Vascular ultrasound; blood pressure; LBNP/PP
box.
Abbreviations: BPS, brachial plexus stimulation; cervicomedullary stimulation; CO, carbon monoxide; DFO, desferrioxamine; EMG, electromyography; LBNP/PP,
lower body negative pressure / positive pressure; NIRS; near infrared spectroscopy; ONSD, optic nerve sheath diameter; PE, phenylephrine; SNP, sodium nitroprusside;
TCD, transcranial doppler; TMS, transcranial magnetic stimulation.
https://doi.org/10.1371/journal.pone.0204660.t001
Fig 1. Schematic of sample sizes and location of study participation.
https://doi.org/10.1371/journal.pone.0204660.g001
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Ethical approval & consent
In accordance with the Declaration of Helsinki, the study was approved by both the UBC Clin-
ical Research Ethics committee and Nepal Health Research Council (NHRC). This research
was carried out within the framework of the Ev-K2-CNR laboratory in collaboration with the
Nepal Academy of Science and Technology as foreseen in the Memorandum of Understanding
between Nepal and Italy, with special thanks to a contribution from the Italian National
Research Council. All potential participants signed the approved consent form—and for each
child, consent was obtained from their respective parent or guardian. Prior to voluntary con-
sent, opportunities for questions were offered at multiple stages in both countries. Sherpa
adults and children were recruited through word of mouth and advertisement. An official
Nepali translation of the consent form was provided with a Nepali physician present to explain
and answer all questions. Further information was provided by one of three local Nepali clini-
cal collaborators. In all locations throughout the expedition, the Nepali translators were pres-
ent to allow for communication between Sherpa and investigators. All participants were free to
withdraw without justification or penalty from all experiments at any time.
Final preparations & ascent profile (Fig 2)
The expedition team assembled in Kathmandu (1400m) 3–9 days prior to departure to Lukla
(2860m). This period was primarily devoted to Sherpa participant baseline testing and making
final equipment preparations. For example, new uninterruptable power supply (UPS) devices
had to be located when two UPS units caught fire in the hotel during baseline testing. While
the availability of electricity in Kathmandu is now much better than ever before, future expedi-
tions conducting testing are advised to find recently built/renovated hotels where wiring is
more robust. The expedition medical kit, ~50L of saline, 100L of liquid nitrogen, and a miscel-
lany of items from diesel to chocolate were purchased and added to the ~six tons of equipment
to be flown and carried to 5050m. Transportation of liquid nitrogen was particularly problem-
atic because: 1) commercial flights cannot technically provide transport, 2) it is difficult to con-
vince local porters that a 100L metal drum releasing gas from the top is not, in fact, a bomb;
and, 3) helicopters cannot technically carry such hazardous materials and are limited in the
Khumbu to visual flight rules. Our shrewd expedition Sirdar was nonetheless able to facilitate
the separate transport of two dewers of liquid nitrogen to and from the Pyramid Laboratory
through a variety of means.
Expedition members flew to Lukla (2860m) over two days, after which they hiked as a
group to the Pyramid Laboratory (5050m) over 9–10 days with obligatory rest / testing days at
3440m (day 4; 2 days) and 4371m (day 7; 2 days). These testing days were scheduled as part of
a conservative acclimatization schedule [10] to mitigate acute mountain sickness and prevent
the need for prophylactic acetazolamide, and were also necessary to complete a range of
Table 2. Participant demographics and morphometrics.
Lowland adults Sherpa adults P-value Lowland children Sherpa children P-value
N (male/female) 25/5 24/0 16/14 28/29
Age (years) 31±9 29±11 0.51 10±1 11±3 0.381
Height (cm) 176±8 169±6 <0.01 143±7 138±16 0.168
Weight (Kg) 73±10 64±11 <0.01 34±6 33±12 0.709
BMI (Kg/m2) 24±3 22±3 0.19 17±2 17±4 0.727
Mean ± StD.
https://doi.org/10.1371/journal.pone.0204660.t002
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studies conducted during ascent. High-altitude medications (e.g., acetazolamide, dexametha-
sone) and oxygen were available at all times in case of an emergency. The majority of the
research team then spent 3 weeks at the Pyramid Laboratory (5050m). Those conducting the
study on Sherpa children left the group at Namche Bazaar and hiked first to Thame (3792m),
and then to Khunde (3853m) to conduct testing over 2 weeks.
Equipment logistics
Over six metric tons of equipment were transported to 5050m in a combination of Pelican
cases (for delicate items; www.pelican.com), waterproof barrels, and duffel bags. Pelican cases
were used to house fragile equipment throughout the trans-continental flights and erratic
ground transport through the Himalaya. Over 50 porters (who were not tested) and 20 yaks
were hired for the transport of our equipment. Approximately 30 K-size gas cylinders (~1500
kg in total) were transported to the Pyramid Laboratory 4–12 weeks in advance. The Sherpa
and lowlander participants carried similar loads (i.e., just personal backpack) on ascent. Ultra-
sound equipment was carried in personal backpacks by the sonographers as their failure
would have compromised nearly every study (Table 1).
Equipment
Researchers will undoubtedly have their own equipment preferences based on economy and
practicality. Some comment on our experiences with various equipment bears mention as the
functionality and durability of equipment in the stresses of the field varies markedly.
Blood. Radiometer ABL90 FLEX (Radiometer, Copenhagen) and i-STAT (Abbot Point of
Care, Princeton, New Jersey) devices were used for the measurement of arterial blood gases.
The upright device (ABL90 FLEX) from Radiometer does function at altitude, but it constantly
demanded recalibration and flushing due to blood clots in the line; a problem seldom encoun-
tered at sea-level. This device also required a constant temperature well above the ambient
Fig 2. Ascent elevation profile for the UBC Scientific Expedition.
https://doi.org/10.1371/journal.pone.0204660.g002
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temperatures usually experienced at altitude. Fortunately, this was possible in certain areas of
the lodge attached to the Pyramid Laboratory. The i-STAT device can be kept warm in a jacket
pocket, uses a small amount of blood, and successfully processed ~300 samples in Kathmandu
and upon ascent. However, at 5050m we did require ~25% more of the single-use disposable
cartridges (model, EG6+) than anticipated due to clotting (which requires a new cartridge).
Indeed, clotting was also an issue with venous blood collection and drug infusions. A large
gauge needle/cannula is recommended as it can be difficult to maintain a patent cannula dur-
ing infusions, and due to greater blood viscosity as well as reduced atmospheric pressure, fill-
ing vacutainers becomes quite problematic. As such, we recommend 18G needles and to
double the size of vacutainers relative to that used at sea-level for a given volume of blood.
Ventilation. Some studies utilized a full PowerLab setup (ADInstruments, Colorado
Springs) but the requirements for a constant, clean electrical supply are problematic. We used
a Wright Analog Spirometer and a digital capnograph (EMMA capnograph, Masimo, Irvine,
CA) to measure minute ventilation and end-tidal PCO2, respectively. These devices are robust,
small, and require no AC power supply, and, together with SpO2, provide an index of ventila-
tory response to altitude [11]. It is important to realize the inaccuracy of pulse oximeters at
SpO2 values below ~70%; hence values should be verified, if possible, with arterial blood sam-
pling [12].
Ultrasound. Echocardiography was performed by two experienced sonographers using
commercially available, portable ultrasound machines (Vivid Q, GE Healthcare, Piscataway,
NJ, USA). These devices have a relatively short battery life (<45 minutes) so access to an AC
power supply was required. Members of the research team have used these devices on numer-
ous high-altitude expeditions, and have found them to be remarkably robust to the inhospita-
ble environmental conditions. Peripheral (via brachial and superficial femoral arteries) and
cerebral (via internal carotid and vertebral arteries) vascular assessments were completed with
Duplex ultrasound (10Hz probe, 15L4, Terason t3200, Burlington, MA, USA), with vessel
diameter and blood velocity measured offline at 30Hz. Data backups were performed daily to
multiple portable encrypted solid state drives.
Microneurography. Studies of sympathetic nerve activity using microneurography are
very rare at high-altitude; to our knowledge only three other studies have been completed [13–
15]. In one of our studies multiunit microneurography recordings of sympathetic outflow in
the peroneal nerve were successfully undertaken by two experienced microneurographers. We
used a Nerve Traffic Analyser consisting of an electrode, a preamplifier and an electronic sys-
tem (662C-3, Bioengineering of University of Iowa, Iowa City, IA). This system proved to be
robust, surviving both the journey to and from the research station. Furthermore, despite the
demanding environment for both researchers and participants, neural signal detection at
high-altitude was good, with high signal to noise ratios, and very few problems caused by elec-
trical interference. This was in contrast to problems encountered in Kathmandu that were
associated with intermittent power supply and electrical interference.
Protocols
Seventeen mechanistic study protocols, some with a number of sub-questions / hypotheses,
were successfully completed at altitudes up to and including 5050m. These core studies
focused on the mechanisms of cerebral blood flow regulation, iron metabolism, pulmonary
pressures, intra-ocular pressures, cardiac function, neuromuscular fatigue, motor control,
blood volume regulation, autonomic control and micro and macro vascular function. The
studies are broadly defined here by those conducted during ascent and those conducted at
5050m (see Table 1 for further details).
UBC-Nepal Expedition to Nepal Himalaya
PLOS ONE | https://doi.org/10.1371/journal.pone.0204660 October 31, 2018 8 / 17
Ascent studies. Using semi-mobile equipment and simple experimental designs six stud-
ies were completed during ascent to 5050m.
Temporary laboratories were situated in Kathmandu (1400m), Namche Bazaar (3440m) and
Pheriche (4371m). The permanent laboratory was at 5050m. Barometric pressure, temperature,
and humidity data were recorded daily at each laboratory and are summarized in Table 3.
For the presented data (see Results), radial artery blood gases were procured in the morn-
ing, in the fasted state, following at least 10-minutes supine rest at each location during the
ascent. A 23-G self-filling catheter (SafePico, Radiometer) was advanced into the radial artery
under local anesthesia (Lidocaine, 1.0%) and ultrasound guidance (Terason, uSmart 3300).
Approximately 1mL of blood was withdrawn anaerobically and immediately assessed using an
arterial blood gas analyzer (i-STAT) for PaO2, the partial pressure of arterial carbon dioxide
(PaCO2), pH, and bicarbonate (HCO3
-).
Studies at 5050m. The Ev-K2-CNR research laboratory at 5050m is one of the finest
high-altitude research facilities in the world (Fig 3). An extensive battery bank charged by a
Table 3. Environmental variables at each testing site.
Site Altitude (m) Temperature Humidity
UBC 344 19 (3) 30(7)
Kathmandu 1400 22 (3) 42 (11)
Namche Bazaar 3440 14 (4) 39 (7)
Pheriche 4371 11 (3) 32(5)
Pyramid Laboratory 5050 9 (5) 29(6)
Mean (±SD). UBC = Kelowna, Pyramid Laboratory = Ev-K2-CNR Research Pyramid Laboratory.
https://doi.org/10.1371/journal.pone.0204660.t003
Fig 3. The Ev-K2-CNR laboratory, 5050m, Solokhumbu, Nepal.
https://doi.org/10.1371/journal.pone.0204660.g003
UBC-Nepal Expedition to Nepal Himalaya
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solar array or diesel generator (during overcast weather) provided electricity routed through
an uninterrupted power supply to maintain stable power as outages sometimes occurred. In
total, this power enabled 2–5 fully functional laboratories to operate for 10–14 hours per day.
Sophisticated blood gas analyzers (ABL90 Flex, Radiometer) were stored and operated in a
temperature controlled room located in the main lodge. The adjoining lodge provided accom-
modation and food for up to 30 participants, with tents for additional persons.
Biological sample storage and transport. During both the ascent and laboratory studies
at 5050m, blood samples were collected from an arm vein and quickly spun in a portable cen-
trifuge (at 2000–3000 RPM, Drucker Diagnostics, Model 642VES, Port Matilda, PA). Serum
and plasma were aliquoted into 2ml cryotubes and stored in liquid nitrogen (-196˚C). Samples
were brought from the field to Kathmandu and shipped to Canada on dry ice (-78.5˚C; Mar-
ken Inc; temperature verified). Iron, transferrin saturation, and ferritin were measured by an
accredited laboratory (Samyak Diagnostic, Kathmandu, Nepal; ISO 15189:2012).
Sample size estimates. Minimum subject sample sizes were determined a priori based on
the specific study. Based on our previous exercise and high-altitude studies (e.g. [16–21]) ade-
quate sample sizes for each of the outlined studies, accounting for potential subject dropout,
were determined by related statistical power calculations whereby a power of 0.8 was assumed,
and an alpha value of 0.05 was set (G�power). Depending on the variability of the primary out-
come of each study (e.g., CBF, PASP, etc.), 8–30 participants were required.
Statistical analyses. The presented arterial blood gas data were analyzed with a linear
mixed effects model utilizing a compound symmetry covariance matrix. The factors were Alti-
tude and Race, with altitude as a repeated measure. Upon detection of a significant interaction
(P<0.05), Bonferroni corrected post-hoc tests were utilized for pairwise comparisons. All sta-
tistical tests were performed with the Statistical Package for the Social Sciences (SPSS, V24).
Results
Arterial blood gas data was successfully collected at each altitude on 21 lowlanders and 11
Sherpa. The results are summarized in Table 4. Changes in PaO2 and SaO2 were not different
between Sherpa and lowlanders. At each altitude PaCO2 was decreased in both groups (Fig 4);
however, PaCO2 was greater in Sherpa at Pheriche and the Pyramid Laboratory (P<0.05 for
both). This, coupled with a lower [HCO3
-] at Kathmandu and Namche Bazaar for Sherpa
(P<0.05 for both), led to a main effect of race for pH (P<0.05). Indeed, the Sherpa were less
alkalotic at each altitude than lowlanders.
Discussion
Although there were numerous setbacks over the course of the expedition that ranged from
the typical illnesses experienced in developing countries to tanks of pure nitrogen instead of
15% oxygen arriving at 5050m, every planned study was successfully completed. Nevertheless,
number of potentially confounding factors still bear consideration to help inform future expe-
ditions to high-altitude.
Sherpa studies and retention of altitude acclimatization
A consistent observation is that following descent to lower elevations, humans retain some of
the acclimatization to high-altitude for some time and show a much faster acclimatization
upon re-ascent [22,23]. For example, in lowlanders, it was recently reported that, after
descending to low altitude from 5260 m for one or three weeks, physiological evidence of accli-
matization persisted upon returning to 5260 m. These changes were manifested by lower AMS
incidence, retention of exercise performance, and, to some extent, ventilatory acclimatization
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(higher PaO2 and lowered PaCO2) and cognitive performance [23]. The questions arises:
Would the Sherpa adults who descended to lower elevations for 5–15 days display some form
of altitude retention and hence be a methodological flaw in our experimental design? There
are three important points to this question. First, our fundamental design was to compare
Table 4. Arterial blood gas data throughout ascent.
Kathmandu Namche Bazaar Pheriche Pyramid Laboratory
PaO2 (mmHg) Altitude, P<0.001; Race, P = 0.489; Interaction, P = 0.649
Lowlander 77.2±6.4 51.9±4.0� 47.6±3.6� 41.2±4.3�
Sherpa 74.8±7.3 52.2±4.8� 46.7±4.7� 40.6±3.6�
SaO2 (%) Altitude, P<0.001; Race, P = 0.143; Interaction, P = 0.794
Lowlander 95.4±1.2 87.4±2.6� 84.5±3.1� 78.9±4.8�
Sherpa 94.5±2.0 86.7±3.3� 82.5±4.8� 77.4±4.2�
PaCO2 (mmHg) Altitude, P<0.001; Race, P = 0.043; Interaction, P = 0.008
Lowlander 40.3±2.5 34.5±1.4� 32.2±1.6�† 30.0±1.9�†
Sherpa 39.8±2.4 35.4±2.4� 34.3±3.0� 32.1±2.5�
HCO3
- (meq/L) Altitude, P<0.001; Race, P = 0.144; Interaction, P = 0.002
Lowlander 26.3±1.4† 23.5±1.3�† 21.5±1.4� 21.4±1.5�
Sherpa 24.6±1.2 22.3±1.7� 21.5±1.9� 21.7±2.1�
pH Altitude, P<0.001; Race, P<0.001; Interaction, P = 0.956
Lowlander 7.42±0.02 7.44±0.02� 7.43±0.02 7.46±0.02�
Sherpa 7.40±0.02 7.41±0.02� 7.40±0.02 7.44±0.02�
Bolded “Lowlander” or “Sherpa” denotes greater values across altitudes, P<0.05 (main effect);
� denotes a difference from Kathmandu, P<0.05;
† denotes a difference between Sherpa and Lowlanders, P<0.05 (Pairwise comparison).
Pyramid Laboratory = Ev-K2-CNR Research Laboratory.
Note that no lowlander or Sherpa children were included in the ascent studies.
The data presented are based on adults only.
https://doi.org/10.1371/journal.pone.0204660.t004
Fig 4. Rahn & Otis curves for Sherpa and lowlander upon ascent to altitude. Lowlanders are denoted by the open
circle symbol (�), and Sherpa by the open square symbol (□). Moving right to left, data are plotted from Kathmandu
(1400m), Namche Bazaar (3400m), Pheriche (4371m), and the Pyramid Laboratory (5050m). � denotes a significant
difference between Sherpa and lowlanders for PaCO2 at a given altitude (P<0.05).
https://doi.org/10.1371/journal.pone.0204660.g004
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Sherpa to lowlanders during ascent to altitude. With acknowledgment that altitude retention
is possible in our Sherpa group, we felt this was an important comparison to make to better
understand how lowlanders respond to altitude when compared to the Sherpa. Second, people
living at high-altitude regularly ascend and descend in the mountainous environment and
hence our design is of practical relevance. Finally, in many of the studies in this investigation,
by including an additional group of Sherpa who did not descend, we have a further compari-
son of those without the potential influence of descent. This final point is also important in
that it allows for an improved ability to dissociate acclimatization from evolutionary differ-
ences that may exist between the lowlander and Sherpa participants. In other words, if a differ-
ence is not observed between lowlanders and the ascending Sherpa, but is observed between
lowlanders and the at-altitude Sherpa, the difference has likely manifested as a result of accli-
matization. If a difference exists between lowlanders and both Sherpa groups, this is more
likely to have manifested as a result of evolutionary adaptation.
Laboratory vs. field
For obvious reasons of ecological validity, we elected to undergo a comparative field study
between lowlanders and Sherpa during ascent and over time at 5050m. Although it would not
have been possible to complete such a study with our sample size in a hypobaric chamber,
there are many uncontrolled variables during a field study. These factors include variable tem-
perature, sample size, diet, exercise / physical inactivity, etc. Of note, in the present set of stud-
ies, these factors were common across participants during ascent and at 5050m. In some ways,
it is almost impossible to fully control the intensity and duration of ascent on an individual
level; however, in other ways, this approach is more realistic of a typical trek and high altitude
where individuals typically walk in groups. Nevertheless, all participants were encouraged to
trek at a conservative pace to avoid overexertion and limit the risk of altitude illness.
Multiple publications
This research study encompassed many collaborators and a range of observational, invasive
and mechanistic physiological experiments with a priori determined aims and hypotheses. As
such, the results will be partitioned into discrete papers led by the coordinating principle inves-
tigator of the experiments. The coordination of large-scale high-altitude research requires
planning, organization and management that typically begins 2–5 years in advance. Expedi-
tions are expensive and require substantial funding. They demand a coordinated approach by
a compatible research team, and the logistical and financial challenges of personnel and equip-
ment transport must be tackled. The transportation of expensive and fragile equipment to
high-altitude regions is a significant final hurdle because conventional carriage is impossible
and there may exist difficulties with importation tax and customs. It is for these reasons that
high-altitude field studies have normally included multiple experimental questions and their
corollary publications, often yielding >10 papers from a single expedition (recent examples
include: AltitudeOMICS [23]; Caudwell Xtreme Everest [10]). Such a research design is some-
times criticized for duplication or overlap of data, but is defensible providing that that any
duplication of data is acknowledged and that publications are not intentionally partitioned,
but rather best packaged to address their respective a priori hypotheses. Moreover, because of
unknown complications and related risks of conducting research at altitude, many of the
planned experiments are unsuccessful; hence, they are never published. Nonetheless, duplica-
tion of data will be limited to variables germane to multiple studies, for example, data from
arterial and venous blood sampling, pulmonary function testing, and standard cardiovascular
variables such as blood pressure and heart rate.
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Translational opportunities
Hypoxemia is commonplace amongst critically and chronically ill patients with optimal man-
agement strategies remaining unclear. The approach of investigating mountaineers exposed to
hypoxia at high-altitude offers the advantage that a relatively homogeneous and healthy popu-
lation can be studied, in contrast to the heterogeneous and generally less healthy patient popu-
lation typically observed in critical care units. While some of the linkages between altitude-
related studies and critical pathologies remain unclear, studies have shed new light on our
understanding of the pathogenesis of various hypoxia-related diseases [e.g., pulmonary edema,
acute respiratory distress syndrome, etc; see [2] for review]. The important clinical links
between oxygen, iron availability and pulmonary pressure regulation have been recently docu-
mented [24,25]. By progressive investigations in the Sherpa, new insight into the mechanisms
that lead to beneficial adaptation may further develop into individualized treatment strategies.
Continuing fieldwork in high-altitude residents is urgent since modernization and migration
are changing the traditional ways of life and patterns of exposure to the environment among
highlanders everywhere. The study of humans at altitude will moreover facilitate explication of
the processes by which humans have evolved to their environments.
A further translatable opportunity that such an expedition offers is career development of
team members. This education occurs on many levels, ranging from undergraduate to gradu-
ate students who, because of the unique training environment, may collect data for presenta-
tions and publications. Perhaps more importantly, the interdisciplinary/collaborative aspect of
this kind of field research provides invaluable experience when things seldom go as planned
(i.e., it fosters ingenuity, adaptability, team work, etc.). Moreover, there were intentionally
many early career researchers, who led their own independent projects within the supported
group. As such, their careers will be further enhanced by the success and networking proffered
by this expedition. The majority of the team are involved with basic science or medical educa-
tion; thereafter, both the experiences and the data collected during these trips will be used in a
range of formal and informal teaching settings.
Sherpa vs. lowlander arterial blood gases during ascent to altitude
A recent review [6] concluded, following the assessment of 21 related papers, that the hypoxic
ventilatory response of Tibetans/Sherpa was not different from lowlanders. Early studies had
suggested a blunting of the hypoxic ventilatory response in Sherpa [26,27], whereas other
reports indicate they may ventilate more at rest [28]. Inevitably, methodological differences
between studies, the acclimatization process, and differences in altitude at which Sherpa and
lowlanders were assessed have all been considered contributory factors to these inconsistent
findings. Further, measurements of minute ventilation (e.g., spirometry) may not be purely
representative of differences in alveolar ventilation between groups, especially considering the
noted differences in lung volumes [29] and diffusion capacity [30]. However, PaCO2 provides
an effective means to index alveolar ventilation that accounts for potential differences in vol-
umes and diffusion capacities [31–36].
PaCO2 ¼
VCO2
VA
Where VA represents alveolar ventilation and VCO2 is metabolic CO2 production. Thus, Rahn
& Otis curves were plotted for the purposes of comparing effective alveolar ventilation between
the Sherpa and lowlander groups across each altitude (Fig 4). As depicted in the figure, it can
be seen that below a PaO2 of ~50mmHg, lowlanders have a downward shift in the curve. This
would indicate that alveolar ventilation is greater in lowlanders under the assumption that
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VCO2 is not different. Given the lower VO2 of Sherpa [6,37], and therefore, VCO2, differences
in alveolar ventilation are underrepresented by the plotted lines. Overall, our arterial blood gas
data, in line with previous small sample size studies [27], indicate that subsequent to a short
de-acclimatization period, Sherpa possess a lower alveolar ventilation (and are hence less alka-
lotic) than lowlanders during the same ascent profile. The lower alveolar ventilation cannot be
attributed to central chemoreceptor drive to breathe as arterial pH was lower, which should
lead to a greater ventilation (under the assumption of comparable changes in brain tissue pH
at the level of the brainstem). Therefore, it is more likely that some form of peripheral chemo-
receptor-mediated adaptation, may be responsible for this difference; however, we acknowl-
edge the regulation of breathing at high-altitude is highly complex [38] and could be altered at
the level of afferent input [39] central integration [40], and/or efferent output [41].
Lessons learned
Invasive human physiology research necessitates a large team of compatible, expert individuals
to complete intricate experimental paradigms. This is especially true of field studies where
it seems that if something can go wrong, it generally will. Our 2016 expedition overcame
numerous problems that could have easily thwarted what was ultimately a success. It is worth
describing herein some of the factors that contributed to each of our planned studies being
completed, if only narrowly, to help with the successful planning of future expeditions.
Local support. There were few moments when the expedition’s Sirdar, Nima Sherpa of
Khunde, was not on a cellular phone coordinating logistics ranging from helicopters to deliv-
ery of several tons of compressed gas canisters by human porters to recruitment and schedul-
ing of local study volunteers. Particularly given the profound differences in language, cultural
norms and business practice, it is imperative to have an efficient and reliable local manager.
Electricity. It is obvious that electricity is necessary, but the importance of a stable, clean
power source needed to run sophisticated equipment cannot be overstated. For example,
despite our electrician designing two uninterrupted power supplies, we caused a number of
power outages, in addition to two contained electrical fires while running baseline studies in a
Kathmandu hotel. Thus, a competent tradesperson or engineer is integral to the success of
such an expedition.
Health. Despite the improbability of non-hypoxia related emergency illness (appendicitis,
for example), evacuation plans and appropriate clinical counterparts are required to aptly han-
dle such situations. In general, the effect of illness on team morale is severe. It is thus impera-
tive to provide good medical care, but also quality food and treats, which together greatly
contribute to the spirit and motivation of the team.
Safety. For our previous expeditions in 2008 and 2012, all compressed gases were shipped
from either Australia or Canada to Nepal, which, while costly and time consuming, guaranteed
the correct gas content. Compressed gases were procured from India in this 2016 expedition
and shipped ahead of the research team to the Pyramid Laboratory. These tanks were found
to vary markedly from their stated composition—more than one was pure nitrogen, which
could have been calamitous had this gas been accidently given to a volunteer. Because of likely
impairment in cognitive function at altitude, it is highly recommended that more than one
investigator confirm the exact mix of compressed gases and double-check correct dosing for
any pharmacological intervention.
Conclusion
The 2016 UBC Expedition was comprised of seventeen studies on five distinct cohorts: 1) 30
lowlander adults; 2) 12 Sherpa adults who de-acclimatized at 1400m for 5–15 days; 3) 12
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Sherpa adults who had not recently descended below 3500m; 4) 57 Sherpa children; 5) 30
age and BMI-matched lowlander children tested in Canada at 344m. Studies were conducted
both during a nine-day trekking ascent to 5050m and during three weeks at 5050m, which
focused on cardiovascular, cerebrovascular, cardiopulmonary and neuromuscular aspects
of human physiological responses to acclimatization. The findings from this study will be
reported in approximately seventeen ensuing publications according to their respective a priori
hypotheses.
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